Literature DB >> 8719797

Relationship between morphine analgesia and cortical extracellular fluid levels of morphine and its metabolites in the rat: a microdialysis study.

M J Barjavel1, J M Scherrmann, H N Bhargava.   

Abstract

1. The effect of morphine (10 mg kg-1, s.c.) on the analgesic response measured by the tail-flick method was determined in male Sprague-Dawley rats. The analgesic response to morphine was correlated with the levels of morphine and its metabolites collected by microdialysis from the cortical extracellular fluid (ECF). 2. The analgesic response to morphine lasted for 4 h. The concentration of morphine during a 4 h collection period was significantly higher than the metabolites concentration. The relative concentration of morphine and its metabolites during the 4 h period was 70 and 30% respectively. 3. The analgesic response during the first 2.25 h period accounted for more than 82% of the total analgesia as determined by the area under the time-response curve (AUC). The concentration of morphine and its metabolites during the same period were 78 and 22%, respectively, but they did not differ during the 2.25-4.0 h period (52 and 48%). 4. The half-life for morphine and its metabolites were similar, the maximal achievable concentration Cmax and AUC0-4 h were lower for metabolites but the time to reach maximum concentration was higher for morphine metabolites than for morphine. The ratio of the concentration of metabolites to the concentration of morphine in the cortical ECF increased with time whereas the analgesic response to morphine decreased with time. 5. At several time points following morphine injection even though the levels of morphine were the same, the concentration of metabolites (mainly M3G) differed and thus the ratio [metabolite/morphine]. A plot of [metabolite]/[morphine] vs. analgesia gave a high correlation coefficient. Since M3G has been shown to be antianalgesic and is the only metabolite of morphine in the rat, it is concluded that the levels of this metabolite may regulate the analgesic effect of morphine in the rat.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719797      PMCID: PMC1909170          DOI: 10.1111/j.1476-5381.1995.tb15125.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Multiple opiate receptors and pharmacological response to morphine in rats maintained on diets differing in protein concentration.

Authors:  H N Bhargava; M Bansinath; S Das; G A Matwyshyn
Journal:  Gen Pharmacol       Date:  1987

2.  Isolation and identification of morphine 3- and 6-glucuronides, morphine 3,6-diglucuronide, morphine 3-ethereal sulfate, normorphine, and normorphine 6-glucuronide as morphine metabolites in humans.

Authors:  S Y Yeh; C W Gorodetzky; H A Krebs
Journal:  J Pharm Sci       Date:  1977-09       Impact factor: 3.534

3.  Analgesic effect of morphine glucuronides.

Authors:  K Shimomura; O Kamata; S Ueki; S Ida; K Oguri; H Yoshimura; H Tsukamoto
Journal:  Tohoku J Exp Med       Date:  1971-09       Impact factor: 1.848

4.  The depression of spinal inhibition by morphine.

Authors:  D R Curtis; A W Duggan
Journal:  Agents Actions       Date:  1969-07

5.  Potential analgesic contribution from morphine-6-glucuronide in CSF.

Authors:  C W Hand; W P Blunnie; L P Claffey; A J McShane; H J McQuay; R A Moore
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

6.  Intrathecal high dose morphine produces hyperalgesia in the rat.

Authors:  C J Woolf
Journal:  Brain Res       Date:  1981-03-30       Impact factor: 3.252

7.  Distribution of UDP-glucuronyltransferase in different human foetal tissues.

Authors:  G M Pacifici; A Rane
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

8.  Morphine excitation: effects on field potentials recorded in the in vitro hippocampal slice.

Authors:  J H Robinson; S A Deadwyler
Journal:  Neuropharmacology       Date:  1980-06       Impact factor: 5.250

9.  Simultaneous measurement of extracellular morphine and serotonin in brain tissue and CSF by microdialysis in awake rats.

Authors:  F F Matos; H Rollema; A I Basbaum
Journal:  J Neurochem       Date:  1992-05       Impact factor: 5.372

10.  Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity.

Authors:  F S Labella; C Pinsky; V Havlicek
Journal:  Brain Res       Date:  1979-10-05       Impact factor: 3.252

View more
  8 in total

1.  Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal.

Authors:  Anna K Radke; Jonathan C Gewirtz
Journal:  Neuropsychopharmacology       Date:  2012-06-13       Impact factor: 7.853

Review 2.  Application of microdialysis in pharmacokinetic studies.

Authors:  W F Elmquist; R J Sawchuk
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

3.  Opiate states of memory: receptor mechanisms.

Authors:  L A Bruins Slot; F C Colpaert
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

Review 4.  Morphine-3-Glucuronide, Physiology and Behavior.

Authors:  Florian Gabel; Volodya Hovhannisyan; Abdel-Karim Berkati; Yannick Goumon
Journal:  Front Mol Neurosci       Date:  2022-05-12       Impact factor: 6.261

5.  Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey.

Authors:  David A White; Stephen G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  2003-03-18       Impact factor: 4.530

6.  Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze.

Authors:  Zhongqi Zhang; Gery Schulteis
Journal:  Pharmacol Biochem Behav       Date:  2008-01-29       Impact factor: 3.533

7.  Changes in fentanyl demand following naltrexone, morphine, and buprenorphine in male rats.

Authors:  Lindsey R Hammerslag; Rebecca S Hofford; Qiwen Kang; Richard J Kryscio; Joshua S Beckmann; Michael T Bardo
Journal:  Drug Alcohol Depend       Date:  2019-12-16       Impact factor: 4.492

8.  Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure.

Authors:  Patrick E Rothwell; Mark J Thomas; Jonathan C Gewirtz
Journal:  Neuropsychopharmacology       Date:  2009-06-03       Impact factor: 7.853

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.